Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c6c7da627b7bead7208250127b52c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_142d981bd6c180968f769e0da8f620da |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f2fc18d727ed6eebe705a188c9677b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e53de1f4dfbc03dc89140e8ded10db54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3fb2e90f4c2e7d0ed86016a25510012 |
publicationDate |
2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20110028082-A |
titleOfInvention |
Cp2 Transcription Factors Involved in Neurodegenerative Diseases |
abstract |
The present invention relates to CP2 transcription factors involved in neurodegenerative diseases. The present invention has the specificity of regulating downstream pathogenic genes in terms of transcriptional mechanisms, which can be treated without side effects such as severe neurogenic disorders caused by conventional methods of inhibiting APP genes or related enzymes. Do. In addition, the present invention provides basic data on the development and treatment of new drugs through the regulation of CP2 transcription factors in the treatment of neurodegenerative diseases (particularly Alzheimer's disease). |
priorityDate |
2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |